What is Sihuan Pharmaceutical Holdings Group Gross Margin %?
Sihuan Pharmaceutical Holdings GroupSHPHF 51 Gross Margin % is 70.97% as of Dec. 2025, which is 0% below its 10-year median of 71.00. GuruFocus rates SHPHF with a GF Score™ of 51/100 and a GF Value™ of $0.18 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 935 Drug Manufacturers companies, Sihuan Pharmaceutical Holdings Group ranks better than 80.96% on this metric.
Sihuan Pharmaceutical Holdings Group (OTCPK:SHPHF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sihuan Pharmaceutical Holdings Group had a gross margin of 70.97% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sihuan Pharmaceutical Holdings Group Gross Margin % Related Terms
Sihuan Pharmaceutical Holdings Group Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group Gross Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sihuan Pharmaceutical Holdings Group Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sihuan Pharmaceutical Holdings Group (SHPHF) has a Gross Margin % of 70.97% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. This is near median its historical median of 71.00. Over the past decade, Sihuan Pharmaceutical Holdings Group's Gross Margin % has ranged from 65.32 to 81.55. According to the industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #178 out of 935 companies in the Drug Manufacturers industry, placing it in the top 19%.
Is Sihuan Pharmaceutical Holdings Group's Gross Margin % too high?
Sihuan Pharmaceutical Holdings Group's current Gross Margin % of 70.97% is near median its 10-year median of 71.00. Over the past 10 years, this metric has ranged from a low of 65.32 to a high of 81.55. The Drug Manufacturers industry median Gross Margin % is 48.54. Sihuan Pharmaceutical Holdings Group's value of 70.97% is 46.2% above this industry median. Based on the distribution chart, Sihuan Pharmaceutical Holdings Group ranks #178 out of 935 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sihuan Pharmaceutical Holdings Group has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sihuan Pharmaceutical Holdings Group's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #178 out of 935 companies for Gross Margin %. This places Sihuan Pharmaceutical Holdings Group in the top 19% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. Sihuan Pharmaceutical Holdings Group's value of 70.97% is 46.2% above this benchmark. Historically, Sihuan Pharmaceutical Holdings Group's own Gross Margin % has ranged from 65.32 to 81.55 over the past decade. While the company's 10-year median is 71.00 vs. the industry median of 48.54, Sihuan Pharmaceutical Holdings Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sihuan Pharmaceutical Holdings Group's current Gross Margin % of 70.97% is 46.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sihuan Pharmaceutical Holdings Group's current Gross Margin % is 70.97%, which is near median its own 10-year median of 71.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sihuan Pharmaceutical Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group (SHPHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.18, compared to a current price of $0.13 — trading 27.9% below its estimated fair value. The current Gross Margin % is 70.97%, which is near median its 10-year median of 71.00 and 46.2% above the Drug Manufacturers industry median of 48.54. Sihuan Pharmaceutical Holdings Group's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sihuan Pharmaceutical Holdings Group (SHPHF), the current Gross Margin % is 70.97% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sihuan Pharmaceutical Holdings Group (SHPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group stock appears to be undervalued.
The current stock price of $0.13 is trading 27.9% below its estimated GF Value™ of $0.18.
GuruFocus considers Sihuan Pharmaceutical Holdings Group to be Modestly Undervalued.
Key valuation signals for SHPHF:
Gross Margin %: 70.97% (near median its 10-year median of 71.00)
GF Value™: $0.18 vs. price of $0.13 (27.9% below fair value)
Industry Position: 46.2% above the Drug Manufacturers median (#178 of 935)
No single metric tells the full story. See the SHPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sihuan Pharmaceutical Holdings Group Business Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
51GF Score
Get the complete analysis for SHPHF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPHF has been successfully added to your 
